Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

205 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +34 more
Locations
  • Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Center for Bleeding Disorders Little Rock, Arkansas, United States
  • Orthopaedic Institute for Children HTC Los Angeles, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
View all 76 locations
View Trial Details
Recruiting

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

NCT05611801

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Arbesu Hematología Mendoza, Argentina
  • Murdoch Children's Research Institute Parkville, Australia
  • Medizinische Universität Wien Vienna, State of Vienna, Austria
  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 64 locations
View Trial Details
Recruiting

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

NCT06003387

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of California, San Diego (UCSD) San Diego, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Hemophilia Center of Western Pennsylvania (HCWP) Pittsburgh, Pennsylvania, United States
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View all 31 locations
View Trial Details
Recruiting

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

NCT07080905

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Center for Inherited Blood Disorders Orange, California, United States
  • University of Florida Gainesville, Florida, United States
  • Arthur M. Blank Hospital - Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

NCT06379789

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
View all 46 locations
View Trial Details
Recruiting

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

NCT06349473

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • California Clinical Trials Medical Group (CCTMG) Glendale, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • LA Center for Bleeding and Clotting Disorders - Metairie Metairie, Louisiana, United States
View Trial Details
Recruiting

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

NCT07644832

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Xiangya Hospital of Central South University Changsha, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jinan Central Hospital Jinan, China
  • The First Hospital of Lanzhou University Lanzhou, China
View Trial Details
Recruiting

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • The Regents of the University of California||UC Davis Health Rancho Cordova, California, United States
  • UC Davis Health Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
View all 23 locations
View Trial Details

Related conditions